An agriculture feed startup has received $9.4 million in initial funding for its technology that produces pure protein from CO2. The protein would come from carbon dioxide generated by industrial exhaust, and would be combined with hydrogen to create scalable, cheap animal feed to replace soybeans—a major feed crop linked heavily with deforestation. Deep Branch combines some of the most basic chemical building blocks, present in everything from stars to skyscrapers—like carbon, oxygen, and hydrogen—inside a fermentation chamber where it produces high-value protein called “Proton.” This Proton is then dried, mixed with other nutrients, and turned into pellets at a 90% CO2 savings rate compared to other feed sources. Attracting support from the biggest feed producers in Europe, as well as carbon-control/sustainable investment funds from financial institutions like Barclays, a Series-A funding round has now been completed with multiple long-term investment commitments. James Ferrier, an investment director at Barclays, said in a statement that “Deep Branch’s technology has the potential to be part of the solution to overcome the biggest environmental challenges of our time.”
Science & Technology
WINNIPEG — It was a clear afternoon when a man driving down a rural road in Alberta with his son saw a pie-shaped object levitating in the sky just before the thing rotated, turned black and suddenly disappeared. “There were no windows, lights, lines or markings on the object’s surface and the edges were all rounded,” says a transcript of the man’s report made to Winnipeg’s Ufology Research.
Researchers say governments need to begin adapting now to the new reality When it comes to climate change, experts say few things have been as tricky to predict as its impact on hurricanes. A new report in the ScienceBrief Review website published last week now suggests that many regions affected by hurricanes will likely experience storms of greater intensity as a result of Earth’s changing climate. Maximum wind speeds in hurricanes could rise five per cent if the planet warms by 2 C by 2100, the review of more than 90 peer-reviewed studies found. And that highlights a need for cities and governments — including those in Canada — to plan ahead for a future where they may be dealing with climate issues they have not had to deal with in the past, experts say. “It’s important that governments look at how you need to adapt to climate change,” said Canadian researcher Corinne Le Quéré, a Royal Society professor of climate change at the University of East Anglia, who edited the report.
For something purportedly “global,” AGW sure is illusive… “INSANE DEPTH OF COLD” TO BLAST BRITAIN An “insane depth of cold” is set to strike the UK over the Easter weekend, warns the Weather Outlook’s Brian Gaze. Freezing temperatures and frosts will arrive in Scotland on Thursday, April 1, with “polar spring” conditions engulfing the majority of the country by Good Friday. Looking further ahead, the mercury is expected to sink even lower during the following week, as a violent kink in the jet stream (associated with the historically low solar activity we continue to experience) delivers Arctic air to the lower-latitudes. Thermometers could sink to -10C (14F) in northern parts, which would topple all-time daily cold records. The UK’s lowest-ever recorded temperature for April 5, for example, is the -9C (15.8F) set in 1990, while 1935’s -8.9C (16F) for April 7 could also tumble. In fact, most of the daily benchmarks between early-to-mid April are under threat, including some that have stood for more than a century.
An oral vaccine could potentially allow for people to self vaccinate at home. An Israeli-American pharmaceutical company is preparing to launch a Phase I clinical trial for what could become the world’s first oral COVID-19 vaccine. Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company based on technology developed by Hadassah-University Medical Center, announced over the weekend a joint venture with India-based Premas Biotech to develop a novel oral vaccine. Together they formed the company Oravax Medical Inc. The vaccine is based on Oramed’s “POD” oral delivery technology and Premas’s vaccine technology.
There’s been buzz lately about mycelium, a material made from fungi that’s being used as a greener substitute for leather and plastic in products such as clothing and packaging. But more than a decade ago, designers were talking about mycelium’s potential for another use — as a building material. This could lead to the construction of healthier buildings made of components that are grown instead of manufactured and can be triggered to biodegrade at the end of their life, instead of piling up as demolition waste in landfills. Mycelium is the root network of fungi, which in nature help decompose materials like wood and leaves, recycling their nutrients and storing their carbon in the soil. But it can also be grown by humans from waste materials such as sawdust or agricultural residues such as plant stalks and husks, recycling them and generating a new material or product within weeks in a low-cost, low-energy process compared to traditional manufacturing. It can even be grown to a particular shape, similar to the way concrete is cast.